Bioventus (BVS) Assets Average (2021 - 2026)

Bioventus' Assets Average history runs 6 years deep, the most recent figure standing at $667.0 million for Q1 2026.

• Quarterly Assets Average fell 6.01% year-over-year to $667.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $667.0 million (down 6.01% YoY) and the FY2025 annual result came in at $705.8 million, down 8.28% from the prior year.
• Assets Average was $667.0 million for Q1 2026 at Bioventus, down from $692.6 million in the prior quarter.
• Across five years, Assets Average topped out at $1.4 billion in Q4 2022 and bottomed at $667.0 million in Q1 2026.
• A 5-year average of $901.7 million and a median of $802.6 million in 2024 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average surged 113.0% — and 2023, when it plunged 41.46%.
• Bioventus' Assets Average stood at $1.4 billion in 2022, then tumbled by 41.46% to $811.0 million in 2023, then decreased by 7.68% to $748.7 million in 2024, then slipped by 7.5% to $692.6 million in 2025, then slipped by 3.69% to $667.0 million in 2026.
• Business Quant data shows BVS's Assets Average at $667.0 million in Q1 2026, $692.6 million in Q4 2025, and $704.2 million in Q3 2025.